Named on one round in the feed.
Since 2026-10-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
seragy holding GmbH A provider of a biomarker strategy platform focused on neurodegenerative diseases and other proteopathies | Finanzierung Verified against 4 of 15 sources | $13.5M | 2026-10-14 | [ PART ] |